medigraphic.com
SPANISH

Medicina Interna de México

Colegio de Medicina Interna de México.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2014, Number 4

<< Back Next >>

Med Int Mex 2014; 30 (4)

Melatonin and its Usefulness in the Daily Practice

Pérez-Beltrán CF, Díaz-Greene EJ, Rodríguez-Weber FL
Full text How to cite this article

Language: Spanish
References: 16
Page: 419-424
PDF size: 423.61 Kb.


Key words:

melatonin, Alzheimer disease.

ABSTRACT

Melatonin in an indolamine, which has an endogenous synthesis by pineal gland, which is regulated by the light-darkness cycle. It has been attributed many therapeutic properties; however, it has been proved its use in the management of insomnia, jet lag, and its antioxidant function. Based on literature, it is known that serum and cerebrospinal fluid concentrations vary depending on people age, whereby decreased levels of melatonin could be related with nerodegenerative processes undergo mainly older adults. It has been studied the usefulness of melatonin to diminish the development of Alzheimer disease; however, there is a lack of information that justify its use in this disease.


REFERENCES

  1. Brzezinski A. Melatonin in humans. N Engl J Med 1997;336:186-195.

  2. Jiménez Genchi A. Actualidades en las aplicaciones clínicas de la melatonina. Revista Mexicana de Neurociencias. 2013;14:39-43.

  3. Tomás-Zapico C. A proposed mechanism to explain the stimulatory effect of melatonin on antioxidative enzymes. J Pineal Res 2005;39:99-104.

  4. Lin L. Melatonin in Alzheimer’s disease. Int J Mol Sci 2013;14:14575-14593.

  5. Webb SM. Role of melatonin in health and disease. Clin Endocrinol (Oxf) 1995;42:221-234.

  6. Reiter RJ. Actions of melatonin in the reduction of oxidative stress. A review. J Biomed Sci 2000;7:444-458.

  7. Benitez-King G. Melatonin as a cytoskeletal modulator: implications for cell physiology and disease. J Pineal Res 2006;40:1-9.

  8. Herxheimer A, Petrie KJ. Melatonin for the prevention and treatment of jet lag (Review). 2009. The Cochrane collaboration.

  9. Sack RL. Jet Lag. N Engl J Med 2010;362:440-447.

  10. Iguchi H. Melatonin serum levels and metabolic clearance rate in patients with liver cirrhosis. J Clin Endocrinol Metab 1982;54:1025-1027.

  11. Hardeland R. Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance. Endocrine 2005;27:119-130.

  12. Maestroni GJ. The immunoneuroendocrine role of melatonin. J Pineal Res 1993;14:1-10.

  13. Reiter RJ. Oxygen radical detoxification processes during aging: the functional importance of melatonin. Aging (Milano) 1995;7:340-351.

  14. Reiter RJ. Oxidative damage in the central nervous system: protection by melatonin. Prog Neurobiol 1998;56:359- 384.

  15. Tan DX. The pineal hormone melatonin inhibits DNA-adduct formation induced by the chemical carcinogen safrole in vivo. Cancer Lett 1993;70:65-71.

  16. Benítez-King G. Haloperidol causes cytoskeletal collapse in N1E-115 cells through tau hyperphosphorylation induced by oxidative stress: Implications for neurodevelopment. Eur J Pharmacol 2010;644:24-31.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Med Int Mex. 2014;30